Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion

Journal of Acquired Immune Deficiency Syndromes

Volumn 53, Issue 4, 2010, Pages 537-543

  Bernstein, Kyle T ^a   Marcus, Julia L ^a   Nieri, Giuliano ^a   Philip, Susan S ^a   Klausner, Jeffrey D ^a  

^a SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

HIV; Men who have sex with men; Rectal chlamydia; Rectal gonorrhea

Indexed keywords

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; RECTUM DISEASE; RETROSPECTIVE STUDY; SEROCONVERSION;

ADULT; CHLAMYDIA INFECTIONS; GONORRHEA; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RECTAL DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 77949401928     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181c3ef29     Document Type: Article

References (44)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2007. Atlanta, GA: Department of Health and Human Services 2009.
2. Scheer S, Chin CS, Buckman A, et al. Estimation of HIV incidence in San Francisco. Aids. 2009;23:533-534.
3. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immu-nosuppression in female sex workers in Abidjan, Cote d'Ivoire. Aids. 1997;11:F85-F93.
4. Kaul R, Kimani J, Nagelkerke NJ, et al. Monthly antibiotic chemopro-phylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA. 2004;291:2555-2562.
5. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet. 1997;349:1868-1873.
6. Dyer JR, Eron JJ, Hoffman IF, et al. Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis. 1998;177:224-227.
7. Zetola N, Bernstein KT, Wong E, et al. Exploring the Relationship Between Sexually Transmitted Diseases and HIV Acquisition by Using Different Study Design. JAIDS. 2009;50:546-551.
8. Chmiel JS, Detels R, Kaslow RA, et al. Factors associated with prevalent human immunodeficiency virus (HIV) infection in the Multicenter AIDS Cohort Study. Am J Epidemiol. 1987;126:568-577.
9. Coates RA, Calzavara LM, Read SE, et al. Risk factors for HIV infection in male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol. 1988;128:729-739.
10. Craib KJ, Meddings DR, Strathdee SA, et al. Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men. Genitourin Med. 1995;71:150-154.
11. Moss AR, Osmond D, Bacchetti P, et al. Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol. 1987;125: 1035-1047.
12. Sheth PM, Sunderji S, Shin LY, et al. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis. 2008;197:1394-1401.
13. Cohen CR, Plummer FA, Mugo N, et al. Increased interleukin-10 in the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS. 1999;13:327-332.
14. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138:923-936.
15. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol. 1989;129:125-137.
16. Grosskurth H, Gray R, Hayes R, et al. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet. 2000;355:1981-1987.
17. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995;346:530-536.
18. Grosskurth H, Mosha F, Todd J, et al. A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results. Aids. 1995;9:927-934.
19. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis. 1998;177:167-174.
20. Sturm-Ramirez K, Gaye-Diallo A, Eisen G, et al. High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus. J Infect Dis. 2000;182:467-473.
21. Nkengasong JN, Kestens L, Ghys PD, et al. Human immunodeficiency virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Cote d'Ivoire. J Infect Dis. 2001;183:1405-1408.
22. Ramsey KH, Schneider H, Cross AS, et al. Inflammatory cytokines produced in response to experimental human gonorrhea. J Infect Dis. 1995;172:186-191.
23. de Jong MA, de Witte L, Oudhoff MJ, et al. TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest. 2008;118:3440-3452.
24. Christodoulides M, Everson JS, Liu BL, et al. Interaction of primary human endometrial cells with Neisseria gonorrhoeae expressing green fluorescent protein. Mol Microbiol. 2000;35:32-43.
25. McGee ZA, Jensen RL, Clemens CM, et al. Gonococcal infection of human fallopian tube mucosa in organ culture: relationship of mucosal tissue TNF-alpha concentration to sloughing of ciliated cells. Sex Transm Dis. 1999;26:160-165.
26. Fichorova RN, Desai PJ, Gibson FC, 3rd, et al. Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun. 2001;69:5840-5848.
27. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis. 2007;44:1222-1228.
28. Gray RH, Wawer MJ, Sewankambo NK, et al. Relative risks and population attributable fraction of incident HIVassociated with symptoms of sexually transmitted diseases and treatable symptomatic sexually transmitted diseases in Rakai District, Uganda. Rakai Project Team. Aids. 1999;13:2113-2123.
29. Detels R, English P, Visscher BR, et al. Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years. J Acquir Immune Defic Syndr. 1989;2:77-83.
30. Rietmeijer CA, Penley KA, Cohn DL, et al. Factors influencing the risk of infection with human immunodeficiency virus in homosexual men, Denver 1982-1985. Sex Transm Dis. 1989;16:95-102.
31. Serwadda D, Wawer MJ, Musgrave SD, et al. HIV risk factors in three geographic strata of rural Rakai District, Uganda. Aids. 1992;6:983-989.
32. Morris M, Kretzschmar M. Concurrent partnerships and the spread of HIV. Aids. 1997;11:641-648.
33. Chauhan M, Sankar KN, Pattman RS. Rectal chlamydia in men attending a GU medicine clinic. Int J STD AIDS. 2004;15:847.
34. Cook RL, St. George K, Silvestre AJ, et al. Prevalence of chlamydia and gonorrhoea among a population of men who have sex with men. Sex Transm Infect. 2002;78:190-193.
35. Manavi K, McMillan A, Young H. The prevalence of rectal chlamydial infection amongst men who have sex with men attending the genitourinary medicine clinic in Edinburgh. Int J STD AIDS. 2004;15: 162-164.
36. Kent CK, Chaw JK, Wong W, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41:67-74.
37. Scheer S, Kellogg T, Klausner JD, et al. HIV is hyperendemic among men who have sex with men in San Francisco: 10-year trends in HIV incidence, HIV prevalence, sexually transmitted infections and sexual risk behaviour. Sex Transm Infect. 2008;84:493-498.
38. Crosby RA. Condom use as a dependent variable: measurement issues relevant to HIV prevention programs. AIDS Educ Prev. 1998;10:548-557.
39. Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993;88:517-526.
40. Macalino GE, Celentano DD, Latkin C, et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002;14:367-378.
41. Morisky DE, Ang A, Sneed CD. Validating the effects of social desirability on self-reported condom use behavior among commercial sex workers. AIDS Educ Prev. 2002;14:351-360.
42. Rhodes SD, DiClemente RJ, Cecil H, et al. Risk among men who have sex with men in the United States: a comparison of an Internet sample and a conventional outreach sample. AIDS Educ Prev. 2002;14:41-50.
43. Saltzman SP, Stoddard AM, McCusker J, et al. Reliability of self-reported sexual behavior risk factors for HIV infection in homosexual men. Public Health Rep. 1987;102:692-697.
44. Zenilman JM, Weisman CS, Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis. 1995;22:15-21.